Our studies suggesting problems with the BBB early in the disease and showing a linear increase in the levels of FN1 in the exosomes of patients' serum implicate the importance of maintaining the stability of the BBB in ALS. This evidence concerns the gene FN1 and amyotrophic lateral sclerosis.